You are currently browsing within Treatment.

Return to Treatment
Zoonotic diseases of bat origin

Building on our knowledge and experience of henipah viruses (Hendra and Nipah viruses) and other bat-borne diseases.

Dr John White, leader of the Laboratory Automation and New Technologies team

Dr John White is responsible for leading the Laboratory Automation and New Technologies team within the Diagnosis, Surveillance and Response Theme at CSIRO's Australian Animal Health Laboratory (AAHL) in Geelong, Victoria, Australia.

Avian Influenza research

To develop a closer understanding of the host-pathogen response to avian influenza.

Canberra: Black Mountain, ACT (Black Mountain laboratories)

CSIRO’s Black Mountain laboratories are the central research facilities of CSIRO Plant Industry, CSIRO Ecosystem Sciences and CSIRO Land and Water.

Dr Christine O'Keefe: turning data into knowledge for informed decision-making

Dr Christine O'Keefe is Program Leader for Decision and User Science in CSIRO Computational Informatics. She turns data into knowledge for informed decision-making and action in the services economy.

Quantitative Imaging: tools for extracting high quality data from images

CSIRO is developing computer vision tools that, like the human eye, can recognise and discriminate between objects but are also able to make detailed, accurate measurements.

Dr Keith McLean: developing biomedical materials to replace or repair damaged body parts

Dr Keith McLean is the Biomedical Materials and Devices Theme Leader focused on developing materials and prototype devices for application in diagnosis, tissue repair, replacement and regeneration.

Dr Scott Martin: leading the development of manufactured devices

Dr Scott Martin is coordinating CSIRO's development of devices with application in industries from medical to aerospace.

Dr Paul Savage: improving drug discovery

Dr Savage develops technologies with application in the biotechnology industry, especially in the area of bioactive molecules.

Advance in bowel cancer test research

Australian researchers have developed gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.

Keeping your colon healthy (Podcast 08 Apr 2009)

Colorectal cancer, also known as colon or bowel cancer, is the second most common type of internal cancer in Australians, with over 12 500 cases diagnosed every year. (5:56)

Sydney: North Ryde, NSW (CSIRO North Ryde)

CSIRO's North Ryde site is in the heart of Sydney's hi-tech hub and near Macquarie University. More than 500 staff members work in mining, food, manufacturing, sustainability, health, petroleum and more.

Dr Ilija Sutalo: investigating fluid dynamics for the medical industry

Dr Sutalo has a strong background in fluid mechanics and has applied his knowledge in a range from fields, including biomedical devices and mining.

Dr David Haylock: Office of the Chief Executive Science Leader

Dr David Haylock is pioneering stem cell research in Australia.

Dr Charles Lindall: commercially responsible for new medical technologies

Dr Charles Lindall works to commercialise new medical technologies, including devices, materials, diagnostics and therapeutics.

Preventative Health Flagship UPDATE

The Preventative Health Flagship’s goal is to improve the health and wellbeing of Australians through the prevention and early detection of chronic diseases. UPDATE is the newsletter containing current news from this initiative.

Preventative Health Flagship overview

The Preventative Health Flagship is working to improve the health and wellbeing of Australians through research into prevention and early detection of common chronic diseases. Flagship research into prevention, early detection and intervention is uncovering new ways to improve the health and well-being of Australians.

Hendra virus

In 1994, a deadly new virus threatened to stop Australia's premier horse race – the Melbourne Cup. This virus is now known as Hendra virus.

Generating better information from health data

Researchers in CSIRO's Preventative Health Flagship are working on ways to prevent disease and improve health outcomes through better use of data.

Sydney: North Ryde, NSW (Riverside Life Sciences Centre)

CSIRO has state-of-the-art biological and chemical laboratories at the Riverside Corporate Park in North Ryde.

Biomedical materials and devices

Our researchers are developing and evaluating new materials and devices for tissue repair, replacement and regeneration.

Bioactive surfaces for medical applications

CSIRO research is aiming to understand the chemistry of surfaces, interfaces, and polymeric thin film coatings, with a particular emphasis on adsorption phenomena and tailored polymeric coatings grown from surfaces.

Dr Tim Hughes: Developing new materials for cell encapsulation

Dr Tim Hughes’ work focuses on the design and synthesis of new polymeric materials for specific biomedical applications.

Dr Roshan Mayadunne: Developing smart materials for the delivery of therapeutic agents

Dr Mayadunne is focused on the design and development of novel materials for medical devices, particularly in the space of smart materials for delivery of therapeutic agents.

Dr Thilak Gunatillake: Advanced drug delivery systems

Dr Mayadunne is focused on the design and development of novel materials for medical devices, particularly in the space of smart materials for delivery of therapeutic agents.

Page 1 of 5